Skip to main content

Table 1 Clinicopathological Characteristics

From: Upregulation of ERp57 promotes clear cell renal cell carcinoma progression by initiating a STAT3/ILF3 feedback loop

Characteristics ERp57 expression ILF3 expression
Low (%) High (%) P value Low (%) High (%) P value
Age
  ≤ 56 years 9 (50.00) 9 (50.00) 0.738 8 (42.11) 11 (57.89) 0.505
  > 56 years 7 (41.18) 10 (58.82) 9 (56.25) 7 (43.75)
Gender
 Male 11 (45.83) 13 (54.17) 1.000 9 (39.13) 14 (60.87) 0.164
 Female 5 (45.45) 6 (54.55) 8 (66.67) 4 (33.33)
Tumor size
  ≤ 7 cm 8 (80.00) 2 (20.00) 0.022 10 (76.92) 3 (23.08) 0.015
  > 7 cm 8 (32.00) 17 (68.00) 7 (31.82) 15 (68.18)
pT status
 pT1- pT2 7 (41.18) 10 (58.82) 0.738 9 (45.00) 11 (55.00) 0.738
 pT3 -pT4 9 (50.00) 9 (50.00) 8 (53.33) 7 (46.67)
pN status
 pN0 12 (52.17) 11 (47.83) 0.476 8 (38.10) 13 (61.90) 0.176
 pN1 –pN3 4 (33.33) 8 (66.67) 9 (64.29) 5 (35.71)
TNM stage
 I-II 9 (42.86) 12 (57.14) 0.739 10 (52.63) 9 (47.37) 0.738
 III-IV 7 (50.00) 7 (50.00) 7 (43.75) 9 (56.25)